Publication: Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis.
| dc.contributor.author | Nikolic, Ivana | |
| dc.contributor.author | Ruiz-Garrido, Irene | |
| dc.contributor.author | Crespo, María | |
| dc.contributor.author | Romero-Becerra, Rafael | |
| dc.contributor.author | Leiva-Vega, Luis | |
| dc.contributor.author | Mora, Alfonso | |
| dc.contributor.author | León, Marta | |
| dc.contributor.author | Rodríguez, Elena | |
| dc.contributor.author | Leiva, Magdalena | |
| dc.contributor.author | Plata-Gómez, Ana Belén | |
| dc.contributor.author | Alvarez Flores, Maria Beatriz | |
| dc.contributor.author | Torres, Jorge L | |
| dc.contributor.author | Hernández-Cosido, Lourdes | |
| dc.contributor.author | López, Juan Antonio | |
| dc.contributor.author | Vázquez, Jesús | |
| dc.contributor.author | Efeyan, Alejo | |
| dc.contributor.author | Martin, Pilar | |
| dc.contributor.author | Marcos, Miguel | |
| dc.contributor.author | Sabio, Guadalupe | |
| dc.contributor.funder | Fundación Lilly | |
| dc.contributor.funder | Marie Curie | |
| dc.contributor.funder | Ministerio de Ciencia y Competitividad (España) | |
| dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | |
| dc.contributor.funder | Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) | |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
| dc.contributor.funder | Asociación Española Contra el Cáncer | |
| dc.contributor.funder | Comunidad de Madrid (España) | |
| dc.contributor.funder | Fundación La Caixa | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Unión Europea. Comisión Europea. 7 Programa Marco | |
| dc.contributor.funder | Unión Europea. Comisión Europea. European Research Council (ERC) | |
| dc.contributor.funder | Fundación BBVA | |
| dc.date.accessioned | 2024-12-04T14:07:06Z | |
| dc.date.available | 2024-12-04T14:07:06Z | |
| dc.date.issued | 2024-06 | |
| dc.description | IN was funded by EFSD/Lilly grants (2017 and 2019), the CNIC IPP FP7 Marie Curie Programme (PCOFUND-2012-600396), an EFSD Rising Star award (2019), and grant MINECO IJC2018-035390-I. IR FPI-MCIN PRE2020-092784. MC was an FPI-MINECO fellow (BES-2017–079711). RRB is a fellow of the FPU Program (FPU17/03847). ML was supported by Spanish grant MINECO-FEDER SAF2015-74112-JIN and Fundación AECC: INVES20026LEIV. ABP-G MG was awarded with FPI BES-2017 − 081381. JV was supported by MICIU/AEI/10.13039/501100011033 and by European Union (grants PID2021-122348NBI00, PLEC2022-009298, PLEC2022-009235 and EQC2021-007053-P), by the Comunidad de Madrid (S2022/BMD-7333-CM), and by “La Caixa” Foundation (LCF/PR/HR22/52420019). MM has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI20/00743 and INT21/00065 to MM and cofunded by the European Union and by Junta de Castilla y León, Spain through projects GRS 2388/A/21 and GRS 2648/A/22 to MM. PM is supported by MICIN-ISCIII-Fondo de Investigación Sanitaria (PI22/01759; PMPTA22/00090-BIOCARDIOTOX) and Comunidad de Madrid (P2022/BMD-7209- INTEGRAMUNE-CM; Spain). GS is a EMBO YIP member, received funding from the following programs and organizations: MCIN PGC2018-097019-BI00; European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement ERC 260464; the EFSD/Lilly European Diabetes Research Programme; Fundación AECC PROYE19047SABI; BBVA Foundation Leonardo Grants Program for Researchers and Cultural Creators (Investigadores-BBVA2017) IN[17]_BBM_BAS_0066; MINECO-FEDER SAF2016-79126-R and PID2019-104399RB-I00, MICIN-FEDER PID2022-138525OB-I00 2023-26; and the Comunidad de Madrid (IMMUNOTHERCAN-CM S2010/BMD-2326 and B2017/BMD-3733), PMP21/00057. GS. MM, JV, JT has been awarded with Infraestructura de Medicina de Precisión asociada a la Ciencia y Tecnología IMPACT-2021 PMP21/00113. Instituto de Salud Carlos III., PDC2021-121147-I00.Convocatoria: Proyectos Prueba de Concepto 2021. Ministerio de Ciencia e Innovación. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). | |
| dc.description.abstract | Obesity is characterized by low-grade inflammation, energy imbalance and impaired thermogenesis. The role of regulatory T cells (Treg) in inflammation-mediated maladaptive thermogenesis is not well established. Here, we find that the p38 pathway is a key regulator of T cell-mediated adipose tissue (AT) inflammation and browning. Mice with T cells specifically lacking the p38 activators MKK3/6 are protected against diet-induced obesity, leading to an improved metabolic profile, increased browning, and enhanced thermogenesis. We identify IL-35 as a driver of adipocyte thermogenic program through the ATF2/UCP1/FGF21 pathway. IL-35 limits CD8 T cell infiltration and inflammation in AT. Interestingly, we find that IL-35 levels are reduced in visceral fat from obese patients. Mechanistically, we demonstrate that p38 controls the expression of IL-35 in human and mouse Treg cells through mTOR pathway activation. Our findings highlight p38 signaling as a molecular orchestrator of AT T cell accumulation and function. | |
| dc.description.peerreviewed | Sí | |
| dc.format.number | 6 | |
| dc.format.page | 2635-2661 | |
| dc.format.volume | 25 | |
| dc.identifier.citation | EMBO Rep. 2024 Jun;25(6):2635-2661. | |
| dc.identifier.journal | EMBO Reports | |
| dc.identifier.pubmedID | 38730210 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/25859 | |
| dc.language.iso | eng | |
| dc.publisher | Oxford University Press | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/PCOFUND-2012-600396 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/FP7/2007-2013 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/ERC/260464 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/MINECO IJC2018-035390-I | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/FPI-MCIN PRE2020-092784 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/BES-2017–079711 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/FPU17/03847 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2015-74112-JIN | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/INVES20026LEIV | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/FPI BES-2017-081381 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/MICIU/AEI/10.13039/501100011033 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PID2021-122348NBI00 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PLEC2022-009298 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PLEC2022-009235 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/EQC2021-007053-P | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/S2022/BMD-7333-CM | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/LCF/PR/HR22/52420019 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI20/00743 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/INT21/00065 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI22/01759 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PMPTA22/00090-BIOCARDIOTOX | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PGC2018-097019-BI00 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PROYE19047SABI | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2016-79126-R | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PID2019-104399RB-I00 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PID2022-138525OB-I00 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/S2010/BMD-2326/IMMUNOTHERCAN-CM | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/B2017/BMD-3733 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PMP21/00057 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PDC2021-121147-I00 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/MICIN/AEI/10.13039/501100011033/CEX2020-001041-S | |
| dc.relation.publisherversion | https://10.1038/s44319-024-00149-y | |
| dc.repisalud.institucion | CNIC | |
| dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Moléculas Reguladoras de los Procesos Inflamatorios | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Adipose Tissue | |
| dc.subject | Obesity | |
| dc.subject | T Regulatory Cells | |
| dc.subject | Thermogenesis | |
| dc.subject | p38 Stress Kinases | |
| dc.title | Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Lack of p38 activation in T cells_EMBO Rep_2024.pdf
- Size:
- 2.1 MB
- Format:
- Adobe Portable Document Format


